Aehr Test Sys SEC Filings

Form 4 overview: On 07/02/2025, Alistair N. Sporck, Vice-President of the Contractor Business Unit at Aehr Test Systems (AEHR), reported several equity transactions.

• Restricted Stock Units granted: 9,253 RSUs with quarterly vesting over four years (1/16 per quarter) and 2,276 RSUs with 25% immediate vesting and the balance vesting quarterly over three years. Both grants were recorded at a cost basis of $0.
• Tax-withholding transaction: 305 shares were automatically withheld at $15.13 to cover taxes on vested RSUs; this is classified as a disposition code “F” and does not represent an open-market sale.
• Post-transaction ownership: Sporck now directly owns 34,120 common shares and indirectly controls 3,993 shares through a trust.
• The filing notes an additional 936 shares received on 04/25/2025 from the termination of the company’s ESOP, included in the total.

No derivative securities were reported. The transactions reflect routine executive compensation and tax-withholding activity, with no cash proceeds to the insider and no change to the company’s share count.

Century Aluminum Co (CENX) – Form 4 insider filing

Director Jarl Berntzen received an annual equity grant of 7,778 restricted stock units (RSUs) on 16-Jun-2025. The award was granted at $0 cost as part of the company’s non-employee director compensation program. All RSUs will vest in full within 12 months, at the next annual meeting, or upon certain accelerated-vesting events. Following the grant, Berntzen’s direct beneficial ownership rises to 208,951 CENX shares, which includes previously vested RSUs that he has elected to defer.

No open-market purchases or sales occurred; the filing merely reports the receipt of equity compensation. The transaction modestly increases insider equity alignment but does not signal a change in fundamental outlook or corporate strategy.

Form 4 filing overview – AEHR Test Systems (AEHR)

Executive Vice President Alberto Salamone reported two equity transactions dated 02 July 2025:

• Acquisition: 18,126 common shares were acquired at $0.00, indicating the vesting/grant of restricted stock units (RSUs). Following this line item, his direct ownership increased to 80,976 shares.
• Tax-withholding disposition: 2,441 shares were automatically withheld at $15.13 per share (transaction code “F”). This was not an open-market sale but satisfied payroll tax obligations tied to the RSU vesting.

Ending beneficial ownership: 78,535 common shares, which still includes unvested RSUs referenced in footnote 3.

The RSU schedule (footnote 1) states that 25 % vests immediately, with the remaining 75 % vesting quarterly over three years, aligning Salamone’s incentives with long-term shareholder value.

No derivative securities were reported. The filing signals continued insider equity exposure with only routine, non-discretionary share withholding. There is no indication of open-market selling pressure.

Aehr Test Systems (AEHR) – Form 4 insider activity: Chief Financial Officer Chris Siu reported several equity transactions dated 07/02/2025.

• Acquisitions: 30,998 and 5,586 common shares acquired at $0 per share through the vesting of restricted stock units (RSUs).
• Disposition: 752 shares automatically withheld at $15.13 to cover tax obligations (transaction code “F” – not an open-market sale).
• Resulting ownership: 77,623 directly held shares after the transactions, plus 4,202 shares held indirectly via a trust.
• Vesting schedule notes indicate quarterly vesting over up to four years; unvested RSUs remain outstanding.

The filing increases the CFO’s direct ownership by roughly 35.8 thousand shares, reinforcing management’s equity stake. No cash purchases or discretionary sales were reported, suggesting the activity is routine compensation-related rather than a signal of changing outlook.

Form 4 overview – Aehr Test Systems (AEHR)

On 07/02/2025, Executive Vice President Alberto Salamone reported the acquisition of 6,609 shares of common stock via a restricted stock unit (RSU) grant recorded at $0 cost. After the award, his direct beneficial ownership rose to 62,850 shares, a total that includes unvested RSUs.

The explanatory note states that one-sixteenth of the RSU award vests every three calendar months, provided employment is maintained. No sales or derivative transactions were disclosed, and Table II shows no option activity. The filing therefore reflects routine equity compensation, not an open-market transaction, and does not by itself signal a directional view on AEHR’s valuation.

Form 4 highlights (AEHR – 07/02/2025): President & CEO Gayn Erickson reported two equity awards and one tax-related share withholding.

• Equity awards: 13,528 and 63,847 restricted stock units (RSUs) were granted at $0 cost, totalling 77,375 new shares. 25 % of one grant vests immediately; the balance vests quarterly over three years. The second grant vests in equal sixteenth-monthly installments.
• Post-transaction ownership: Direct holdings rise to 280,570 shares; an additional 291,088 shares are held indirectly via trust, bringing total beneficial ownership to roughly 571,658 shares.
• Tax withholding: 1,822 shares (code F) were withheld at $15.13 solely to cover taxes on vesting; this is not an open-market sale and represents <0.3 % of Erickson’s total holdings.

The sizeable RSU grants expand the CEO’s stake and link future compensation to share-price performance, signalling alignment with shareholders. No discretionary sales were made, and the only disposition was administrative, suggesting a neutral-to-slightly-positive governance signal without immediate earnings or cash-flow impact.

Microchip Technology Inc. (MCHP) Form 4 filed 07/03/2025 reports new equity incentives for Senior Vice President, Worldwide Client Engagement, Joseph R. Krawczyk II.

Current ownership: Krawczyk continues to hold 15,269 common shares directly; no shares were bought or sold.

Derivative grants made on 07/01/2025:

• 1,570 Performance Stock Units (PSUs) tied to achieving a 29.0% cumulative non-GAAP operating margin over 12 quarters ending 06/30/2028; earned shares vest 08/15/2029.
• 111 PSUs with the same performance metric, vesting 08/15/2028.
• Restricted Stock Units (RSUs): 67 vesting 08/15/2027, 111 vesting 08/15/2028, and 1,569 vesting 08/15/2029.

All awards convert 1-for-1 into common stock at a $0 exercise price if service requirements are met. Total new potential shares: 3,428.

Investment view: The grants strengthen long-term alignment between management compensation and profitability goals without immediate cash cost or insider selling. Dilution risk is minimal given Microchip’s large share base, but the awards signal management’s focus on maintaining at least a 29% non-GAAP operating margin through FY2028.

The Charles Schwab Corporation (SCHW) – Form 4 Insider Filing

On 1 July 2025, director Marianne C. Brown reported the acquisition of 412 restricted stock units (RSUs) under the company’s Directors’ Deferred Compensation Plan II. The equity was taken in lieu of cash board fees and is held in a rabbi trust until she leaves the Board of Directors. After the grant, Brown’s direct beneficial ownership rose to 6,525.39 RSUs, a figure that includes 18.88 units gained through dividend reinvestment. No shares were sold or disposed of, and no option exercises occurred. Because the transaction represents routine, non-cash director compensation rather than an open-market purchase or sale, it is considered to have minimal immediate market impact but modestly strengthens director–shareholder alignment.

Aehr Test Systems (AEHR) – Form 4 Insider Transaction

Director Howard T. Slayen reported the award of 9,253 shares of common stock on 07/02/2025. The transaction code “A” indicates an acquisition from the issuer, and the stated price of $0 confirms the shares were granted as equity compensation, not open-market purchases. After the award, Slayen’s total beneficial ownership rose to 229,967 shares, which includes unvested restricted stock units (RSUs).

The RSUs vest in equal eighths each quarter, provided the director remains on the Board. No derivative securities were involved, and there were no dispositions.

Although the grant marginally increases outstanding shares, the size is immaterial relative to AEHR’s float. However, the equity-based award modestly strengthens alignment between the director and shareholders.